BlackRock reports sub‑5% stakes in four firms

BlackRock, Inc. (BLK) reported a series of Schedule 13G and amendment filings on April 28, 2026, outlining its beneficial ownership positions in four U.S.-listed companies. The filings cover stakes in ARS Pharmaceuticals, Summit Midstream Corp., Spire Global, Inc., and Peoples Bancorp of North Carolina Inc., each showing holdings below the 5 percent threshold of outstanding common shares.

In a filing related to ARS Pharmaceuticals, Inc., BlackRock reported beneficial ownership of 4.98% of the company’s common stock. The disclosure was made through an amendment, indicating an updated position in the biopharmaceutical firm. The filing notes that various persons have the right to receive or direct the receipt of dividends or proceeds from the sale of these securities, but no individual person holds more than five percent of ARS Pharmaceuticals’ total outstanding common shares.

The amendment further states that a listing of the shareholders of an investment company registered under the Investment Company Act of 1940, or the beneficiaries of an employee benefit plan, pension fund, or endowment fund, is not required in this context. This language is consistent across BlackRock’s filings for the other issuers reported on the same date.

BlackRock also reported a 4.9% stake in Summit Midstream Corp., corresponding to 612,798 shares of the company’s common stock. As with the ARS Pharmaceuticals filing, the Schedule 13G notes that various persons may have the right to receive or direct the receipt of dividends and sale proceeds for the Summit Midstream shares.

The filing specifies that no single person’s interest in Summit Midstream’s common stock exceeds five percent of the total outstanding common shares. This indicates that BlackRock’s reported position, while significant, remains below the level at which an individual holder would cross the five percent threshold.

For Spire Global, Inc., BlackRock reported holding 1.69 million shares of common stock in a Schedule 13G filing. The document explains that, in line with SEC Release No. 34-39538 dated January 12, 1998, the Schedule 13G reflects securities beneficially owned or deemed to be beneficially owned by certain business units of BlackRock and its subsidiaries and affiliates, referred to collectively as the Reporting Business Units.

The filing clarifies that it does not include securities, if any, that might be beneficially owned by other BlackRock business units whose holdings are disaggregated under that SEC release. Similar to the other disclosures, it states that various persons have rights to dividends or sale proceeds, and that no one person’s interest in Spire Global’s common stock is more than five percent of the total outstanding shares.

In another amendment filing, BlackRock reported holding 259,426 shares of PEOPLES BANCORP OF NORTH CAROLINA INC., representing 4.8% of the company’s common stock. The language in this amendment mirrors the other filings, indicating that multiple persons may direct the receipt of dividends or proceeds from any sale of these shares.

The document reiterates that no individual person’s interest in Peoples Bancorp of North Carolina’s common stock exceeds five percent of the total outstanding common shares. As with the other April 28, 2026 filings, detailed lists of underlying shareholders or beneficiaries in investment companies, employee benefit plans, pension funds, or endowment funds are not required to be provided.